Clinere — Class II drug recall D-0679-2026
Ongoing recall by Bell Pharmaceuticals, Inc, reported 2026-07-22, distributed nationwide. SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
| Recall number | D-0679-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bell Pharmaceuticals, Inc, Belle Plaine, MN, United States |
| Recall initiated | 2026-06-25 |
| Classified | 2026-07-14 |
| Reported by FDA | 2026-07-22 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| NDC | 68229-0102, 68229-0102-01, 68229-0102-02, 68229-0102-03 |
Product
Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bottle of Clinere Carbamide Peroxide (0,50 fl. oz. (15 mL), Dist. by: Quest Products LLC, Pleasant Prairie, WI 53158, NDC 68229-102-01.
Reason for recall
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0679-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.